Literature DB >> 7752915

Hemolysis in primary lipoprotein lipase deficiency.

B Cantin1, S Boudriau, M Bertrand, L D Brun, C Gagné, P A Rogers, M R Ven Murthy, P J Lupien, P Julien.   

Abstract

A slight to moderate hemolysis is often present in plasma from patients with primary lipoprotein lipase (LPL) deficiency. To determine the nature of this hemolysis, we measured erythrocyte hypo-osmotic fragility, plasma free hemoglobin, and phospholipid composition in 26 patients with primary LPL deficiency and 21 unrelated controls. In some patients, these investigations were completed by erythrocyte cytoskeletal protein determinations and abdominal echography. Osmotic fragility was similar between control subjects and patients. However, there was a significantly increased concentration of plasma free hemoglobin in primary LPL deficiency (0.282 +/- 0.331 v 0.048 +/- 0.038 g/L in controls, P < .005). In LPL-deficient patients, an increase of plasma lysophosphatidylcholine concentration (12.6% +/- 5.8% v 6.4% +/- 1.9% in controls, P < .0001) was also found. The protein composition of the erythrocyte membrane skeleton was abnormal in some LPL-deficient patients and splenomegaly was present in 12, but these abnormalities did not correlate with plasma free hemoglobin levels. Bilirubin and haptoglobin levels were also within physiologic ranges in these patients, suggesting that the observed hemolysis did not result from hypersplenism. It appears likely that the accumulation of lysophosphatidylcholine was due to an impairment in the reverse metabolic pathway converting lysophosphatidylcholine back to phosphatidylcholine. Collectively, these data, along with a positive correlation between plasma free hemoglobin and lysophosphatidylcholine levels (r = .58, P = .0001), suggest that the hemolysis observed in primary LPL deficiency is mediated to some extent by the abnormally elevated concentration of lysophosphatidylcholine.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7752915     DOI: 10.1016/0026-0495(95)90124-8

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  3 in total

1.  Severe hypertriglyceridaemia in a Greek infant: a clinical, biochemical and genetic study.

Authors:  Emmanuel Kavazarakis; Stella Stabouli; Dimitrios Gourgiotis; Katerina Roumeliotou; Joanne Traeger-Synodinos; Apostolos Bossios; Andrew Fretzayas; Emmanuel Kanavakis
Journal:  Eur J Pediatr       Date:  2004-06-05       Impact factor: 3.183

2.  Genetic colocalization atlas points to common regulatory sites and genes for hematopoietic traits and hematopoietic contributions to disease phenotypes.

Authors:  Christopher S Thom; Benjamin F Voight
Journal:  BMC Med Genomics       Date:  2020-06-29       Impact factor: 3.063

3.  The use of the rapid osmotic fragility test as an additional test to diagnose canine immune-mediated haemolytic anaemia.

Authors:  Geert Paes; Dominique Paepe; Evelyne Meyer; Annemarie T Kristensen; Luc Duchateau; Miguel Campos; Sylvie Daminet
Journal:  Acta Vet Scand       Date:  2013-10-25       Impact factor: 1.695

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.